FDA Inspection 1237587 - Avista Pharma Solutions, Inc. dba Cambrex - May 03, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Avista Pharma Solutions, Inc. dba Cambrex, with an inspection on May 3, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Avista Pharma Solutions, Inc. dba Cambrex
Inspection Date: May 3, 2024
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · d49d28da-b239-4a0c-8f51-8a56a673d5d4